Characterization of PI3K class IA isoforms with regulatory subunit p55α using a scintillation proximity assay

Analytical Biochemistry

Volumn 383, Issue 2, 2008, Pages 311-315

  Aller, Glenn S Van ^a   Carson, Jeff D ^a   Fernandes, Christine ^a   Lehr, Ruth ^a   Sinnamon, Robert H ^a   Kirkpatrick, Robert B ^a   Tummino, Peter J ^a   Luo, Lusong ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Cancer; Catalytic; p55 ; Phosphoinositide 3 kinase; Scintillation proximity assay; Splice variant

Indexed keywords

CHEMICAL ACTIVATION; DISEASES; ENZYMES; GENE ENCODING; SCINTILLATION;

CANCER; CATALYTIC; GENE AMPLIFICATION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNITS; SPLICE VARIANTS; STEADY-STATE KINETICS;

CATALYST ACTIVITY;

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN P55ALPHA; PROTEIN P85; REGULATOR PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; HUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTISCANNING; STEADY STATE;

EID: 54249085296     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.08.037     Document Type: Article

References (22)

1. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
2. Wymann M.P., Zvelebil M., and Laffargue M. Phosphoinositide 3-kinase signalling-which way to target?. Trends Pharmacol. Sci. 24 (2003) 366-376
3. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S.M., Riggins G.J., Willson J.K.V., Markowitz S., Kinzler K.W., Vogelstein B., and Velculescu V.E. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
4. Bader A.G., Kang S., Zhao L., and Vogt P.K. Oncogenic PI3K deregulates transcription and translation. Nat. Rev. Cancer 5 (2005) 921-929
5. Kang S., Denley A., Vanhaesebroeck B., and Vogt P.K. Oncogenic transformation induced by the p110beta, -{gamma}, and -{delta} isoforms of class I phosphoinositide 3-kinase. Proc. Natl. Acad. Sci USA 103 (2006) 1289-1294
6. Denley A., Kang S., Karst U., and Vogt P.K. Oncogenic signaling of class I PI3K isoforms. Oncogene 27 (2007) 2561-2574
7. Vanhaesebroeck B., Leevers S.J., Panayotou G., and Waterfield M.D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22 (1997) 267-272
8. Fruman D.A., Cantley L.C., and Carpenter C.L. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85α gene. Genomics 37 (1996) 113-121
9. Miled N., Yan Y., Hon W.C., Perisic O., Zvelebil M., Inbar Y., Schneidman-Duhovny D., Wolfson H.J., Backer J.M., and Williams R.L. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317 (2007) 239-242
10. Carson J.D., Van Aller G., Lehr R., Sinnamon R.H., Kirkpatrick R.B., Auger K.R., Dhanak D., Copeland R.A., Gontarek R.R., Tummino P.J., and Luo L. Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase. Biochem. J. 409 (2008) 519-524
11. Ueki K., Algenstaedt P., Mauvais-Jarvis F., and Kahn C.R. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit. Mol. Cell. Biol. 20 (2000) 8035-8046
12. Gray A., Olsson H., Batty I.H., Priganica L., and Peter Downes C. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 313 (2003) 234-245
13. Sittampalam G.S., Kahl S.D., and Janzen W.P. High-throughput screening: advances in assay technologies. Curr. Opin. Chem. Biol. 1 (1997) 384-391
14. Nagata Y., and Burger M.M. Wheat germ agglutinin: molecular characteristics and specificity for sugar binding. J. Biol. Chem. 249 (1974) 3116-3122
15. Gout I., Dhand R., Hiles I.D., Fry M.J., Panayotou G., Das P., Truong O., Totty N.F., Hsuan J., Booker G.W., Campbell I.D., and Waterfield M.D. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75 (1993) 25-36
16. Gelkop S., Babichev Y., and Isakov N. T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein. J. Biol. Chem. 276 (2001) 36174-36182
17. Ren S.Y., Xue F., Feng J., and Skorski T. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase. Exp. Hematol. 33 (2005) 1222-1228
18. Inukai K., Funaki M., Nawano M., Katagiri H., Ogihara T., Anai M., Onishi Y., Sakoda H., Ono H., Fukushima Y., Kikuchi M., Oka Y., and Asano T. The N-terminal 34 residues of the 55 kDa regulatory subunits of phosphoinositide 3-kinase interact with tubulin. Biochem. J. 346 (2000) 483-489
19. Antonetti D.A., Algenstaedt P., and Kahn C.R. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell. Biol. 16 (1996) 2195-2203
20. Okamoto T., Namikawa K., Asano T., Takaoka K., and Kiyama H. Differential regulation of the regulatory subunits for phosphatidylinositol 3-kinase in response to motor nerve injury. Mol. Brain Res. 131 (2004) 119-125
21. Spender L.C., Lucchesi W., Bodelon G., Bilancio A., Karstegl C.E., Asano T., Dittrich-Breiholz O., Kracht M., Vanhaesebroeck B., and Farrell P.J. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55{alpha} regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. J. Gen. Virol. 87 (2006) 2859-2867
22. Marone R., Cmiljanovic V., Giese B., and Wymann M.P. Targeting phosphoinositide 3-kinase-moving towards therapy. Biochim. Biophys. Acta 1784 (2008) 159-185